Business Wire6d
Journal of the American Medical Association (JAMA) Study Provides Further Evidence that CEL-SCI’s Multikine Can Treat Unmet Need in ~70% of Head and Neck Patient…
Journal of the American Medical Association study provides further evidence that Multikine can treat unmet need in ~70% of ...
EurekAlert!2d
HKU researchers uncover key mechanisms driving oral cancer spread and highlight potential treatment strategies
A collaborative research team from The University of Hong Kong (HKU) and West China Hospital of Sichuan University has made a ...
Drug found 'remarkably' effective in common canine oral cancer
Dogs that have oral squamous cell carcinomas often need surgery that disfigures their jaws and lower their quality of ...
Targeted Oncology7h
Tislelizumab Gains FDA Nod in Advanced Esophageal Cancer
Harry H. Yoon, MD, MHS, discusses tislelizumab and platinum-containing chemotherapy in unresectable or metastatic esophageal squamous cell carcinoma whose tumors express PD-L1 at a level of 1 or ...
Clinical Trials Arena on MSN1d
Biofrontera enrols all subjects in trial of topical gel for actinic keratoses
US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz ...
Managed Healthcare Executive10d
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with ...
The Scientist8d
Mapping the Shift from Healthy Stem Cells to Oral Cancer
Single-cell analysis revealed the molecular triggers that drive stem cells to become cancerous, which may help inform ...
Researchers uncover key mechanisms driving oral cancer spread and highlight potential treatment strategies
A collaborative research team from The University of Hong Kong (HKU) and West China Hospital of Sichuan University has made a breakthrough in understanding the spread of oral squamous cell carcinoma ...